- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
C
CLLS
Cellectis
1.400
-0.110-7.28%Pre Market: 1.430 +0.030 +2.14%06:12 10/02 EDT
OPEN/PREV CLOSE1.350/1.400
TODAY RANGE1.330-1.400
VOL62.43K
MARKET CAP97.42M
52 WEEK RANGE1.250-5.48
AVG VOL (3M)77.88K
% TURNOVER0.08%
TURNOVER--
P/E (TTM)-2.0615
% RANGE5.00%
EPS(TTM)-0.6500
P/E(FORWARD)-1.6634
P/B2.372
BVPS0.5649
DIVIDEND--
P/S1.218
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP97.42M
SHARES OUTSTANDING72.70M
NEXT EARNINGS11/05-11/09
FREE FLOAT72.70M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·09/16 14:11
Cellectis: An 'All Or Nothing' Pivot To In-Vivo Gene Editing Is Worth Monitoring
Benzinga·09/16 14:10
This Nu Holdings Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
TipRanks·09/16 13:45
Starbucks initiated, Expedia downgraded: Wall Street’s top analyst calls
Benzinga·09/16 13:10
Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday
Dow Jones·09/16 12:59
Cellectis Cut to Underweight From Overweight by Barclays
Dow Jones·09/16 12:59
Cellectis Price Target Cut to $1.30/Share From $9.00 by Barclays
Benzinga·09/16 12:50
Barclays Downgrades Cellectis to Underweight, Lowers Price Target to $1.3
Benzinga·09/16 12:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TipRanks·09/16 09:00
Cellectis downgraded to Underweight from Overweight at Barclays
Seeking Alpha·09/15 17:33
Cellectis falls as Citizens downgrades on pivot to genetic medicines
Benzinga·09/15 14:04
This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
TipRanks·09/15 13:41
Ulta Beauty, Etsy upgraded: Wall Street’s top analyst calls
Dow Jones·09/15 12:53
Cellectis Price Target Cut to $3.00/Share From $4.00 by Wells Fargo
Dow Jones·09/15 12:53
Cellectis Is Maintained at Equal-Weight by Wells Fargo
Dow Jones·09/15 12:52
Cellectis Is Maintained at Outperform by Baird
Same Industry
Name/Symbol
Change%
Price